Abstract and Poster Submission - 2016

THE ABSTRACT SUBMISSION DEADLINE EXPIRED ON MAY 15TH 2016

You can download document in PDF format pdffrom this link.

The organizing Scientific Committee of the 18th ESVOT Congress invites authors to submit scientific abstracts for podium presentation at Congress. Papers from practitioners are particularly welcome. A maximum of two papers from each author will be accepted.
The selected free communications will be included in the main scientific program.
With reference to Small Animals, clinical and research free communications will be evaluated for acceptance only if pertinent to the session topics of the Congress:

  • Patellar Luxation
  • Issues in joint replacement
  • Hot topics

Free Communications must be written and presented in En-glish. Fifteen (15) minutes will be allotted for the presentation of each paper, which should include a short discussion time. Abstracts should report recent clinical research; preliminary findings and single case reports will be considered. Reviews are not acceptable. Research abstracts must have ethical re-view approval. Research must not have been published nor accepted for publication by the closing date of submission MAY 15th 2016, 12.00 p.m. local time (GMT+1).
All abstracts are reviewed by the conference scientific committee which reserves the right to select abstracts rele-vant to the sessions and topics and decides on the final form of the presentation (oral or poster presentation).
Once the review process of all submitted abstracts is com-pleted, authors will receive an e-mail informing whether the abstract has been accepted and whether it has been se-lected for a poster or for an oral presentation.
All contributions, either oral or poster, must be submitted and presented by a registered conference participant. Sub-mission without conference attendance will not be accepted. The presenting author of each accepted abstract must ap-ply for the Congress and will receive a 30% reduction on the Congress registration fee. Submitted abstracts will be accepted and published in the conference proceedings on-ly on receipt of full registration payment.
Abstracts will be accepted in digital form only and must be prepared according to the following instructions.

Abstracts are to be submitted online! The deadline for submission is MAY 15th, 2016 12.00 p.m. local time (GMT+1). Authors whose abstracts have been accepted will be notified by June 15th, 2016. For abstract submission please go to the ABSTRACT SUBMISSION CENTRE at web site http://abstract.evsrl.it/

To access to the ABSTRACT SUBMISSION CENTRE it is ne-cessary to get a user name and a password for the EGO Sy-stem.
Should you do not have user name and password, please go to EGO Home Page at http://ego.evsrl.it/.
Username and password will be sent in 48 hours.
The ABSTRACT SUBMISSION CENTRE will guide you fil-ling up the following fields:

1. ABSTRACT FORMAT

A single abstract is required: text length should be 8.000 characters including spaces. This will be evaluated by the Programme Committee and if accepted published on Or-thoVetSuperSite.

2. TITLE

Title of work must be in CAPITAL LETTER, maximum length 180 characters including spaces.

3. SUBJECT

4. ADDRESS FOR CORRESPONDENCE

5. AUTHORS

  • Max. 7 authors. Mark the presenting author with an aste-risk.
  • Indicate affiliation to an institute with superscript num-bering e.g., Smith T1, Patterson C2.
  • Enter institutes in numerical sequence after the para-meter <Institution> e.g.
    1 XXXXXX, 2XXXXXX

6. TEXT AND BIBLIOGRAPHY

Please, use the following examples as abstract template:
EXAMPLE
SHORT COMMUNICATION FULL ABSTRACT
(Proceedings)
Total length 8000 characters
UPWARD FIXATION OF THE PATELLA IN HORSES: PREVALENCE AND RESULTS OF CONSERVATIVE TREATMENT
M. Dumoulin, F. Pille, P. Desmet, A. Martens, F. Gasthuys Dept of Surgery and Anaesthesiology of Domestic Animals, Faculty of Veterinary Medicine, Ghent University,
Casinoplein 124, Gent, Belgium

Introduction
The purpose of the present study was to asses the inciden-ce of upward fixation of the patella (UFP), to determine the type of patients affected with this condition and to evalua-te the effectiveness of conservative treatment, with particu-lar emphasis on the efficacy of corrective trimming and/or shoeing (CTS). The authors have used CTS in horses with UFP for years, but the use of this treatment lacked scienti-fic evidence. In a recent study however Back et al. (2003) investigated the effect of a lateral heel wedge on stifle joint motion of trotting Shetland ponies. The present study eva-luates the outcome of this measure in the long term.
 
Materials and methods
Medical records of horses diagnosed with UFP between 1991 and 2003 at the veterinary teaching hospital, Ghent Universi-ty were analyzed retrospectively. Diagnosis of UFP was based on descriptions given by owners and clinical observation of the horses at the time of admission. Only records of patients with complete intermittent or permanent UFP treated conser-vatively were selected. CTS consisted of rotating the hoof cap-sule outward by trimming selectively the inside hoofwall or by applying a lateral heel wedge. Medial breakover was en-couraged by rounding the toe medially or by applying a shoe rounded at the medial aspect of the toe.When indicated, ad-ditional treatment was installed to improve the horse’s condi-tion. A reference population consisted of all orthopaedic pa-tients admitted during the same period.

Results
Of 10227 orthopaedic patients admitted during the observa-tion period, 556 (5,5%) were diagnosed with a stifle disorder. Seventy-eight of them suffered from complete intermittent or permanent UFP (13,8%). One third of the horses with UFP was admitted in November and December. Shetland and other ponies were significantly more represented than other breeds. Mean age at evaluation was 3,9 years (range betwe-en 7 months and 15 years) and there was no sexpredisposi-tion. CTS was performed in 71 horses which showed inter-mittent complete UFP on a regular basis. Follow-up evalua-tion was possible in 64 of them for a period ranging from 4 months up to 12 years. In 26 horses (40,6%), correcting the foot position was successful in eliminating all clinical signs and no UFP was seen as long as foot position was adjusted. Thirteen horses (20,3%) showed a partial improvement as a result of correcting foot position: locking of the patella still oc-curred but at a lower frequency and duration. Altogether, a positive effect of correcting hoof position was seen in all 39 horses (60,9%). On inquiry it appeared that in those cases, no other measures beside CTS had been taken. In none of the horses adverse effects related to CTS were observed, even if this measure had been applied for several years. In 7 horses (10,6%), improvement could not directly be linked to correc-ting foot position alone, because symptoms didn’t disappear immediately. In 6 of those 7 horses, improvement was attai-ned only after improving the horse’s physical condition. In 18 cases (28,1%), conservative treatment was not successful.

Conclusion
UFP affects mainly young horses and ponies during win-ter months. CTS is an easy and harmless measure that is worth trying before more radical procedures to correct UFP are performed.

References
Back W., Remmen J.L.M.A., Knaap J., De Koning J.J. (2003). Ef-fect of lateral heel wedges on sagittal and transverse plane kine-matics of trotting Shetland ponies and the influence of feeding and training regimes. Equine Veterinary Journal 35, 606-612.

An ESVOT Award of € 500,00 will be presented to the win-ner of the best Short Communication at the banquet on Sa-turday, September 10th, 2016.

 

GUIDELINES FOR SUBMISSION OF POSTERS
The total area of the poster should be 1.30 m in height and 0.80 m in width. The text of the poster should include the title, author or authors and their affiliation. The text should be of sufficient size that the poster can be read from a mi-nimum distance of one meter. Results can be presented using graphs and pictures, again bearing in mind the mini-mum viewing distance. Posters should be attached to mounting boards using velcro provided by the organiza-tion. They must be displayed in the viewing area on the first day of the Congress and remain until the end of it. Submission of posters should be by MAY 15th 2016, 12.00 pm local time (GMT+1).
All posters are reviewed by the conference scientific com-mittee which reserves the right to select the most relevant abstracts.
Once the review process of all submitted abstracts is com-pleted, authors will receive an e-mail informing whether the abstract has been accepted for a poster presentation. All contributions, either oral or poster, must be submitted and presented by a registered conference participant. Sub-mission without conference attendance will not be accep-ted. The presenting author of each accepted abstract must apply for the Congress and will receive a 30% reduction on the Congress registration fee. Submitted abstracts will be accepted and published in the conference proceedings on-ly on receipt of full registration payment. Poster should be sent to the following e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Acceptance will be notified by June 15th, 2016. Discussion of the posters is scheduled on Friday, Septem-ber 9th, 2016 at 5:30 PM. At least one author must be pre-sent at this time.

An ESVOT Award of € 500,00 will be presented to the winner of the best Poster at the banquet on Saturday, September 10th, 2016.

 

ESVOT POLICY ON THE USE OF ANIMALS IN RESEARCH
ESVOT’s aims are to promote and advance the standards of or-thopaedics and traumatology in veterinary species through cli-nical research and training. We encourage robust clinical and translational research in the area of veterinary orthopaedics. Such research may often involve prospective or retrospective studies on animals or ex vivo or in vitro studies on animal tis-sues. Studies on veterinary patients should not involve unne-cessary interventions with the sole purpose of research; in other words, all interventions on veterinary patients should be for the intended benefit of the individual animal. All such research should have local Ethics Committee approval as well as any lo-cal, regional or national licences when required; abstracts sub-mitted should state this is the case when indicated.
As a scientific society concerned with the health and welfare of animals, ESVOT acknowledges that sometimes research on animals is necessary for the benefit of human and animal he-alth. However, we strongly support the 3R tenets of Russell and Burch, namely ‘replacement, refinement and reduction’ of animals in research, as supported by the International Council for Laboratory Animal Science (www.iclas.org) and embedded in the European Union Directive 2010/63/EU (http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:EN:PDF).
Moreover, ESVOT will not accept any studies for presentation or publication that involve the use of live dogs, cats, horses or non-human primates in invasive experimentation.

FOR FURTHER INFORMATION PLEASE CONTACT ESVOT SECRETARIAT@EMOVA
THE EUROPEAN MANAGEMENT OFFICE FOR VETERINARY ASSOCIATIONS:
Palazzo Trecchi - Via Trecchi 20 - 26100 Cremona (Italy)
Phone 0039 0372 403509 - Fax 0039 0372 403558
E mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ESVOT thanks the Sponsors for the invaluable support and contribution they are providing to the realization of the 18th ESVOT Congress.

Gold Sponsors:

Elanco Logo


logo kyon

ESVOT application 2016

It's time to renew your ESVOT membership for 2016 to mantain the benefits of being ESVOT Member.

EGO E.V. Edizioni Veterinarie

Click here to know how to register to ESVOT

Esvot Proceedings

members

Guidelines for submission of posters

The total area of the poster should be 1.30 m in height and 0.80 m in width.
The text of the poster should include the title, author or authors and their affiliation. The text should be of sufficient size that the poster can be read from a minimum distance of one meter. Results can be presented using graphs and pictures, again bearing in mind the minimum viewing distance.

Posters should be attached to mounting boards using velcro provided by the organization. They must be displayed in the viewing area on the first day of the Congress and remain until the end of it.

Submission of posters should be by MAY 15th 2014, 12.00 pm local time (GMT+1).
All posters are reviewed by the conference scientific committee which reserves the right to select the most relevant abstracts. Once the review process of all submitted abstracts is completed, authors will receive an e-mail informing whether the abstract has been accepted for a poster presentation.

All contributions, either oral or poster, must be submitted and presented by a registered conference participant. Submission without conference attendance will not be accepted.
The presenting author of each accepted abstract must apply for the Congress and will receive a 30% reduction on the Congress registration fee.

Submitted abstracts will be accepted and published in the conference proceedings only on receipt of full registration payment. Poster should be sent to the following e-mail: info@emova.it Acceptance will be notified by June 15th, 2014.

An ESVOT Award of € 500,00 will be presented to the winner of the best Poster at the banquet on Saturday, October 4th, 2014.

Discussion of the posters is scheduled on Saturday, October 4th, 2014 at 5:30 PM. At least one author must be present at this time.

ESVOT POLICY ON THE USE OF ANIMALS IN RESEARCH

ESVOT’s aims are to promote and advance the standards of orthopaedics and traumatology in veterinary species through clinical research and training. We encourage robust clinical and translational research in the area of veterinary orthopaedics. Such research may often involve prospective or retrospective studies on animals or ex vivo or in vitro studies on animal tissues. Studies on veterinary patients should not involve unnecessary interventions with the sole purpose of research; in other words, all interventions on veterinary patients should be for the intended benefit of the individual animal. All such research should have local Ethics Committee approval as well as any local, regional or national licences when required; abstracts submitted should state this is the case when indicated. As a scientific society concerned with the health and welfare of animals, ESVOT acknowledges that sometimes research on animals is necessary for the benefit of human and animal health. However, we strongly support the 3R tenets of Russell and Burch, namely ‘replacement, refinement and reduction’ of animals in research, as supported by the International Council for Laboratory Animal Science (www.iclas.org) and embedded in the European Union Directive 2010/63/EU (http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010: 276:0033:0079:EN:PDF).

Moreover, ESVOT will not accept any studies for presentation or publication that involve the use of live dogs, cats, horses or non-human primates in invasive experimentation.

Use of cookies: to ensure functionality and navigation preferences This site uses cookies owners, in order to enhance the experience of its members, and reserves the use of third-party cookies to improve our services. For more information and to receive any instructions on the use of cookies please read our extended, pressing the End key accept the use of cookies.